Soukeye Niang
Gerontology · Silver Spring, MDNPI 1881159093
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $687 and has fallen 93.1% since, to $47 in 2024.
Across 59 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$241
- AbbVie$185
- Lilly USA, LLC$162
- GSK$133
- Exact Sciences$86
- Novo Nordisk$78
- plus $347 from 11 others
What the payments were for
- Food & beverage$1,232100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 12 | $241 |
| AbbVie | 8 | $185 |
| Lilly USA, LLC | 8 | $162 |
| GSK | 6 | $133 |
| Exact Sciences | 4 | $86 |
| Novo Nordisk | 4 | $78 |
| AstraZeneca | 3 | $64 |
| Biohaven Pharmaceuticals, Inc. | 2 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $45 |
| Phadia US Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Corcept Therapeutics | 1 | $28 |
| Amgen | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Gilead | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
How this compares
$1,232 in reported general payments places this provider in the 80th percentile of 108 gerontology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 35 | $12,382 |
| Lacosamide | 17 | $9,587 |
| JardianceEmpagliflozin | 22 | $7,482 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $1,607 |
| Famotidine | 23 | $1,533 |
| Levetiracetam | 16 | $1,278 |
| Potassium Chloride | 48 | $1,190 |
| Mirtazapine | 36 | $1,042 |
| Ondansetron Hcl | 25 | $921 |
| Oxycodone Hcl | 41 | $668 |
| Atorvastatin Calcium | 45 | $540 |
| Metoprolol Tartrate | 43 | $538 |
| Levothyroxine Sodium | 32 | $485 |
| Gabapentin | 24 | $475 |
| Hydralazine Hcl | 33 | $474 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $241 | $12,38235 claims |
| GSKAnoro Ellipta | $133 | $1,60712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 108 gerontology providers in Maryland.
Other gerontology in Silver Spring
- Akberet GirmaySilver Spring$2K
- Sissi HernandezSilver Spring$1K
- Tizita TessemaSilver Spring$687
- Christi DieterichElkridge$15K
- Megan GessfordLeonardtown$12K
- Valdane RobinsonTowson$10K
- Victoria SinibaldiBaltimore$10K
- Angeline WilliamsCatonsville$6K
- Wingnay CherneskyParkville$5K
- Joyce LamWaldorf$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.